[Congressional Record Volume 167, Number 145 (Tuesday, August 10, 2021)]
[Senate]
[Pages S6300-S6301]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3079. Mr. COTTON submitted an amendment intended to be proposed by 
him to the concurrent resolution S. Con. Res. 14, setting forth the 
congressional budget for the United States Government for fiscal year 
2022 and setting forth the appropriate budgetary levels for fiscal 
years 2023 through 2031; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO HEALTH 
                   CARE, WHICH MAY INCLUDE PROHIBITING FUNDING FOR 
                   CERTAIN GAIN-OF-FUNCTION RESEARCH.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to health 
     care, which may include prohibiting any Federal funding for 
     gain-of-function research project that may be reasonably 
     anticipated to confer attributes to the influenza, MERS, or 
     SARS virus such that the virus would have enhanced 
     pathogenicity or transmissibility in mammals, by the amounts 
     provided in such legislation for those purposes, provided 
     that such legislation would not increase the deficit over 
     either the period of the total of fiscal years 2022 through 
     2026 or the period of the total of fiscal years 2022 through 
     2031.

[[Page S6301]]

  

                                 ______